Skip to Main Content

Author Details

Stephen K Anderson
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1984
104
37
PMIDPaper TitleJournal TitlePublished Year
37169743Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcome.Cell Death Dis2023
37711632Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability.Front Immunol2023
37645658High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection.Curr Res Immunol2023
36375380Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density.Redox Biol2022
35858344Genetic variation that determines <i>TAPBP</i> expression levels associates with the course of malaria in an HLA allotype-dependent manner.Proc Natl Acad Sci U S A2022
36230818HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation.Cancers (Basel)2022
34209132Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment.Int J Mol Sci2021
32134744Minimal PD-1 expression in mouse and human NK cells under diverse conditions.J Clin Invest2020
31998314Tuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing.Front Immunol2020
32759296Ascorbic Acid Promotes <i>KIR</i> Demethylation during Early NK Cell Differentiation.J Immunol2020
32784501Genetic and Epigenetic Regulation of the Smoothened Gene (SMO) in Cancer Cells.Cancers (Basel)2020
32219494Tuning of human NK cells by endogenous HLA-C expression.Immunogenetics2020
29634348Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism.Antioxid Redox Signal2019
30152521Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.Br J Pharmacol2019
31471108Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons.Immunity2019
31231651The Human <i>TET2</i> Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities.Front Cell Dev Biol2019
29329284Identification of an elaborate NK-specific system regulating HLA-C expression.PLoS Genet2018
30232844Molecular evolution of elements controlling HLA-C expression: Adaptation to a role as a killer-cell immunoglobulin-like receptor ligand regulating natural killer cell function.HLA2018
30270560Identification of trophoblast-specific elements in the HLA-C core promoter.HLA2018
29559979Association of <i>TNFRSF1B</i> Promoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required.Front Immunol2018
27819678TET2 binds the androgen receptor and loss is associated with prostate cancer.Oncogene2017
27467282Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Pro1 element in gene activation, not gene expression.Genes Immun2016
26656451Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes.Genes Immun2016
27817866HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region.Am J Hum Genet2016
28033606Correction: Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells.PLoS Biol2016
27500644Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells.PLoS Biol2016
24634493Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.J Immunol2014
25474109Interleukin-1 and interferon-γ orchestrate β-glucan-activated human dendritic cell programming via IκB-ζ modulation.PLoS One2014
24989671Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression.Genes Immun2014
25181276Probabilistic bidirectional promoter switches: noncoding RNA takes control.Mol Ther Nucleic Acids2014
24842371Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.J Exp Med2014
24563253Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.J Immunol2014
23450696Epigenetic regulation of NK cell differentiation and effector functions.Front Immunol2013
23911940Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant2013
23863987Identification of a KIR antisense lncRNA expressed by progenitor cells.Genes Immun2013
23675302LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells.PLoS Pathog2013
23752612Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.J Immunol2013
22661295Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts.Hum Genet2012
23226525Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance.PLoS One2012
22968455CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.Blood2012
20971950A novel role for IL-22R1 as a driver of inflammation.Blood2011
21411970Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.J Innate Immun2011
21498673Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.Blood2011
20033655Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes.Methods Mol Biol2010
20631304Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells.J Immunol2010
18987359The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.Blood2009
19383797Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.Proc Natl Acad Sci U S A2009
18453594Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?J Immunol2008
19008943Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.PLoS Genet2008
18528402Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.Genes Immun2008
  • 1 - 50 of 104

Recommended Authors

Jakob Micha??lsson
Center for Infectious Medicine, Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 0
Bernard Khor
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1998
Number of shared co-authors 0
Michael Rehli
University Hospital Regensburg
Career Start Year 1995
Number of shared co-authors 0
Yong-Joon Chwae
Ajou University School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Alexander Tarakhovsky
The Rockefeller University
Career Start Year 1994
Number of shared co-authors 0
Christoph Klein
Kinderklinik und Kinderpoliklinik der Ludwig-Maximilians-Universitat Munchen
Career Start Year 1993
Number of shared co-authors 0
Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 0
Andrew Wakeham
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 2
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 5
Kaoru Saijo
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
David L Wiest
Fox Chase Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Karen Cerosaletti
Center for Translational Immunology
Career Start Year 1985
Number of shared co-authors 1
Toshio Kitamura
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0
Timothy W Behrens
Genentech Inc.
Career Start Year 1983
Number of shared co-authors 1
Anjana Rao
La Jolla Institute for Immunology
Career Start Year 1983
Number of shared co-authors 0
Cornelis Murre
University of California
Career Start Year 1982
Number of shared co-authors 1
Timothy J Ley
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 2
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
Richard J Bram
Mayo Clinic College of Medicine
Career Start Year 1980
Number of shared co-authors 0
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Brian Van Ness
University of Minnesota
Career Start Year 1978
Number of shared co-authors 1
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 0
Jeremy M Boss
Emory University School of Medicine
Career Start Year 1976
Number of shared co-authors 0
Louise C Showe
The Wistar Institute
Career Start Year 1975
Number of shared co-authors 2
Daniel G Tenen
Harvard Stem Cell Institute, Harvard Medical School
Career Start Year 1975
Number of shared co-authors 0
Yuichi Obata
RIKEN BioResource Research Center
Career Start Year 1975
Number of shared co-authors 0
Katherine A Siminovitch
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1974
Number of shared co-authors 3
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 3
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

Hongchuan Li
Frederick National Laboratory for Cancer Research
Co-authored papers 25
Daniel W McVicar
National Cancer Institute
Co-authored papers 21
Paul W Wright
University of Virginia School of Medicine
Co-authored papers 11
Howard A Young
Center for Cancer Research, National Cancer Institute
Co-authored papers 10
Mary Carrington
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 8
John C Roder
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 7
Michael Dean
National Cancer Institute
Co-authored papers 6
Jami Willette-Brown
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers 5
William J Murphy
Co-authored papers 4
Matthew McCullen
Washington University School of Medicine
Co-authored papers 4
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 2
Lyudmila A Lyakh
National Institute of Allergy and Infectious Diseases
Co-authored papers 2
Vivek Naranbhai
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Joseph F Boland
National Cancer Institute, National Institutes of Health, Inc.
Co-authored papers 2
Robert N Hoover
National Cancer Institute
Co-authored papers 2
Galit Alter
Co-authored papers 2
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Joseph F Fraumeni
National Cancer Institute
Co-authored papers 2
Stephen T C Wong
Houston Methodist Research Institute
Co-authored papers 2
Margaret A Tucker
National Cancer Institute
Co-authored papers 2
Marcus Altfeld
Co-authored papers 2
Lisa Mirabello
National Cancer Institute
Co-authored papers 1
Laura Quigley
National Cancer Institute-Frederick
Co-authored papers 1
Sholom Wacholder
National Cancer Institute
Co-authored papers 1
Stephanie J Weinstein
Co-authored papers 1
Lionel Feigenbaum
Science Applications International Corporation/Frederick
Co-authored papers 1
Release 1.2